FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Valeant Pharmaceuticals North America Nifedipine Extended-Release Tablets Recall

Nifedipine Extended-Release Tablets, USP, 90 mg, 100 Tablet Bottles, Rx Only

Valeant Pharmaceuticals North America LLC · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Jun 17, 2015
Recall ID
D-1116-2015
Check your lot numberHow we source this data

Summary

Valeant Pharmaceuticals North America recalled Nifedipine Extended-Release Tablets starting Apr 17, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1116-2015 on Jun 17, 2015. Reason: Failed Dissolution Specifications: High out of specification dissolution result at 1 hour time point. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: High out of specification dissolution result at 1 hour time point.

Product description

Nifedipine Extended-Release Tablets, USP, 90 mg, 100 Tablet Bottles, Rx Only. Manufactured for: Teva Pharmaceuticals USA Sailorsville, PA 13960. Manufactured in Canada By: Valeant Pharmaceuticals International, Inc. Steinbach, MB R5G 127 Canada. NDC: 0093-2059-01.

Lot numbers, UPCs & expiration codes

Lot #: 1309T27; Expiry: 8/15; Lot #: 1309T28, Expiry: 8/15; Lot #: 1311T33, Expiry: 10/15; Lot #: 1311T34, Expiry: 10/15, Lot #: 1312T40, Expiry: 11/15; Lot #: 1312T41, Expiry: 11/15; Lot #: 1403T23, Expiry: 02/16; Lot #: 1403T21, Expiry: 02/16; Lot #: 1405T21, Expiry: 04/16; Lot #:1405T22, Expiry: 04/16.

Where it was sold

United States Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1116-2015
Classification
Class II
Status
Terminated
Recall initiated
Apr 17, 2015
FDA report date
Jun 17, 2015
Quantity
93,237 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Valeant Pharmaceuticals North America LLC

Original FDA data

Every field from FDA enforcement report D-1116-2015, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
71328
Address
400 Somerset Corporate Blvd
Code information
Lot #: 1309T27; Expiry: 8/15; Lot #: 1309T28, Expiry: 8/15; Lot #: 1311T33, Expiry: 10/15; Lot #: 1311T34, Expiry: 10/15, Lot #: 1312T40, Expiry: 11/15; Lot #: 1312T41, Expiry: 11/15; Lot #: 1403T23, Expiry: 02/16; Lot #: 1403T21, Expiry: 02/16; Lot #: 1405T21, Expiry: 04/16; Lot #:1405T22, Expiry: 04/16.
Postal code
08807-2867
Report date
Jun 17, 2015
Product type
Drugs
Recall number
D-1116-2015
Classification
Class II
Recalling firm
Valeant Pharmaceuticals North America LLC
Product quantity
93,237 Bottles
Termination date
Apr 12, 2016
Reason for recall
Failed Dissolution Specifications: High out of specification dissolution result at 1 hour time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nifedipine Extended-Release Tablets, USP, 90 mg, 100 Tablet Bottles, Rx Only. Manufactured for: Teva Pharmaceuticals USA Sailorsville, PA 13960. Manufactured in Canada By: Valeant Pharmaceuticals International, Inc. Steinbach, MB R5G 127 Canada. NDC: 0093-2059-01.
Distribution pattern
United States Nationwide
Recall initiation date
Apr 17, 2015
Initial firm notification
Letter
Center classification date
Jun 8, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1116-2015, published Jun 17, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls